| Primary |
| Colorectal Cancer Metastatic |
27.3% |
| Colorectal Cancer |
24.4% |
| Rectal Cancer |
8.3% |
| Colon Cancer |
5.8% |
| Acute Lymphocytic Leukaemia |
4.1% |
| Product Used For Unknown Indication |
3.7% |
| Colon Cancer Metastatic |
3.3% |
| Metastases To Lung |
3.3% |
| Premedication |
2.9% |
| Brain Neoplasm Malignant |
2.5% |
| Vomiting |
2.5% |
| Adenocarcinoma Of Colon |
1.7% |
| Metastatic Colorectal Cancer |
1.7% |
| Pain |
1.7% |
| Chemotherapy |
1.2% |
| Gastric Cancer |
1.2% |
| Metastases To Ovary |
1.2% |
| Neoplasm |
1.2% |
| Rectosigmoid Cancer |
1.2% |
| Medication Dilution |
0.8% |
|
| Febrile Neutropenia |
14.6% |
| Neutropenia |
9.8% |
| Sepsis |
7.3% |
| Vomiting |
7.3% |
| Cardio-respiratory Arrest |
4.9% |
| Chest Pain |
4.9% |
| Fistula |
4.9% |
| Hypersensitivity |
4.9% |
| Peripheral Sensory Neuropathy |
4.9% |
| Proteinuria |
4.9% |
| Pseudomonal Sepsis |
4.9% |
| Small Intestinal Obstruction |
4.9% |
| Tumour Lysis Syndrome |
4.9% |
| Abdominal Distension |
2.4% |
| Arrhythmia |
2.4% |
| Cardiomyopathy |
2.4% |
| Cerebral Haemorrhage |
2.4% |
| Colitis |
2.4% |
| Diarrhoea |
2.4% |
| Disease Progression |
2.4% |
|
| Secondary |
| Colorectal Cancer Metastatic |
29.1% |
| Colorectal Cancer |
17.5% |
| Colon Cancer |
14.3% |
| Gastric Cancer |
6.8% |
| Drug Use For Unknown Indication |
6.1% |
| Product Used For Unknown Indication |
4.4% |
| Colon Cancer Metastatic |
2.9% |
| Prophylaxis |
2.5% |
| Hypertension |
2.1% |
| Metastatic Gastric Cancer |
2.1% |
| Rectal Cancer |
2.0% |
| Pain |
1.4% |
| Neoplasm Malignant |
1.3% |
| Premedication |
1.3% |
| Bone Sarcoma |
1.1% |
| Metastases To Liver |
1.1% |
| Chemotherapy |
1.0% |
| Nausea |
1.0% |
| Neoplasm |
0.9% |
| Metastatic Colorectal Cancer |
0.8% |
|
| Vomiting |
14.2% |
| Disease Progression |
13.5% |
| Death |
6.4% |
| Pyrexia |
6.4% |
| Thrombocytopenia |
6.2% |
| Pulmonary Embolism |
5.6% |
| Sepsis |
5.2% |
| Neutropenia |
4.6% |
| General Physical Health Deterioration |
4.2% |
| Pneumonia |
3.9% |
| Diarrhoea |
3.6% |
| Weight Decreased |
3.5% |
| Dyspnoea |
3.0% |
| Febrile Neutropenia |
3.0% |
| Urinary Tract Infection |
2.9% |
| Respiratory Failure |
2.8% |
| Septic Shock |
2.8% |
| Stomatitis |
2.8% |
| Thrombosis |
2.7% |
| Renal Failure Acute |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.4% |
| Colorectal Cancer Metastatic |
11.9% |
| Colon Cancer |
10.9% |
| Product Used For Unknown Indication |
9.1% |
| Colorectal Cancer |
8.7% |
| Colon Cancer Metastatic |
6.0% |
| Hiv Infection |
4.8% |
| Premedication |
4.0% |
| Rheumatoid Arthritis |
3.6% |
| Prophylaxis |
3.3% |
| Rectal Cancer |
2.5% |
| Acute Lymphocytic Leukaemia |
2.4% |
| Prophylaxis Against Graft Versus Host Disease |
1.9% |
| Adenocarcinoma Of Colon |
1.8% |
| Chemotherapy |
1.7% |
| Surgical Preconditioning |
1.6% |
| Non-hodgkin's Lymphoma |
1.5% |
| Metastases To Liver |
1.4% |
| Spindle Cell Sarcoma |
1.2% |
| Liver Metastases |
1.1% |
|
| Vomiting |
18.8% |
| Pulmonary Embolism |
7.6% |
| Renal Failure Acute |
7.1% |
| Thrombocytopenia |
7.1% |
| Pyrexia |
6.4% |
| Death |
6.2% |
| Disease Progression |
4.5% |
| Toxicity To Various Agents |
4.3% |
| Neutropenia |
4.0% |
| Respiratory Failure |
4.0% |
| Myocardial Infarction |
3.8% |
| Hypotension |
3.1% |
| Loss Of Consciousness |
3.1% |
| Malaise |
3.1% |
| Mucosal Inflammation |
3.1% |
| Hyperammonaemic Encephalopathy |
2.9% |
| Rash |
2.9% |
| Sepsis |
2.9% |
| Febrile Neutropenia |
2.6% |
| Nausea |
2.6% |
|
| Interacting |
| Colorectal Cancer |
40.0% |
| Diffuse Large B-cell Lymphoma |
32.0% |
| Drug Use For Unknown Indication |
12.0% |
| Rectal Cancer Metastatic |
12.0% |
| Atrial Fibrillation |
4.0% |
|
| Myocardial Infarction |
40.0% |
| Fat Embolism |
20.0% |
| Neutropenia |
20.0% |
| Pulmonary Granuloma |
20.0% |
|
